Karyopharm Therapeutics Inc.
KPTI
$7.46
$1.1518.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.25M | -23.46M | -30.78M | -32.07M | 23.79M |
| Total Depreciation and Amortization | 78.00K | 78.00K | 81.00K | 83.00K | 91.00K |
| Total Amortization of Deferred Charges | 2.72M | 2.57M | 2.36M | 2.41M | 1.40M |
| Total Other Non-Cash Items | 5.71M | -16.65M | -6.88M | -350.00K | -54.30M |
| Change in Net Operating Assets | 10.05M | -1.53M | 9.41M | 10.48M | -9.47M |
| Cash from Operations | -18.70M | -38.98M | -25.81M | -19.45M | -38.50M |
| Capital Expenditure | -- | -- | 53.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.29M | 15.29M | 14.74M | 7.47M | 51.26M |
| Cash from Investing | 18.29M | 15.29M | 14.80M | 7.47M | 51.26M |
| Total Debt Issued | -- | -- | 0.00 | 83.30M | -- |
| Total Debt Repaid | -- | -- | 0.00 | -40.52M | -- |
| Issuance of Common Stock | 356.00K | -- | 680.00K | 0.00 | 772.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -42.78M | 40.19M |
| Cash from Financing | 356.00K | -- | 680.00K | 0.00 | 40.97M |
| Foreign Exchange rate Adjustments | 8.00K | 5.00K | -20.00K | 36.00K | -11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.00K | -23.69M | -10.35M | -11.94M | 53.72M |